Pacenta, H. L., & Macy, M. E. (2018). Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma. Drug Des Devel Ther.
Citación estilo ChicagoPacenta, Holly L., y Margaret E. Macy. "Entrectinib and Other ALK/TRK Inhibitors for the Treatment of Neuroblastoma." Drug Des Devel Ther 2018.
Cita MLAPacenta, Holly L., y Margaret E. Macy. "Entrectinib and Other ALK/TRK Inhibitors for the Treatment of Neuroblastoma." Drug Des Devel Ther 2018.
Precaución: Estas citas no son 100% exactas.